📗 Cite This Artifact
RNF128 (Graf1/XTP3) Gene
Overview
Overview
RNF128 (Ring Finger Protein 128), also known as Graf1 or XTP3, is an E3 ubiquitin ligase encoded by the RNF128 gene located on chromosome Xq22.3. The protein plays a critical role in the ubiquitin-proteasome system, where it catalyzes the transfer of ubiquitin to target proteins, marking them for degradation or modifying their function["@rnf"]. Originally identified in T cells as a gene induced during T cell activation, RNF128 has since been implicated in various biological processes including immune regulation, endoplasmic reticulum stress responses, and more recently, neurodegenerative disease pathogenesis["@grafer2021"].
Gene Information
| Attribute | Value |
|-----------|-------|
| Gene Symbol | RNF128 |
| Aliases | Graf1, XTP3, GRAF1, Grail |
| Chromosomal Location | Xq22.3 |
| Gene ID | 56221 |
| Protein Class | E3 Ubiquitin Ligase |
| Molecular Weight | ~46 kDa |
| UniProt ID | Q9H6X0 |
Protein Structure and Function
RNF128 contains a C3HC4 RING finger domain at its N-terminus, which is characteristic of E3 ubiquitin ligases that facilitate the transfer of ubiquitin from E2 conjugating enzymes to substrate proteins. The protein is primarily localized to the endoplasmic reticulum (ER) and possesses a transmembrane domain that anchors it to ER membranes[@rnf].
Key Functional Domains
- RING Finger Domain: C3HC4-type zinc finger responsible for E3 ligase activity; mediates transfer of ubiquitin to substrates
- Transmembrane Region: ER anchor domain that localizes the protein to the endoplasmic reticulum membrane
- Proline-Rich Region: Contains potential protein-protein interaction motifs that may recruit signaling partners
Catalytic Mechanism
E3 ubiquitin ligases like RNF128 serve as substrate recognition modules in the ubiquitin-proteasome system[@komander2009]. The RING finger domain coordinates two zinc ions and provides a platform for bringing together the E2 ubiquitin-conjugating enzyme and the substrate protein. This proximity enables transfer of ubiquitin from the E2 to lysine residues on the substrate, a critical step in protein degradation signaling[@kumar2015].
Expression Pattern
RNF128 is expressed predominantly in:
- Brain tissue (especially hippocampus and cortex)
- Testis
- Liver
- Kidney
- Activated T cells
The gene shows higher expression in neuronal tissues, suggesting specialized functions in neural cells[@rnf]. In the brain, RNF128 expression has been detected in both neurons and glia, with particular enrichment in regions associated with learning and memory.
RNF128 Family and Evolution
RNF128 belongs to a family of ER-associated E3 ubiquitin ligases that includes:
- RNF128 (Grail): The founding member, induced in activated T cells
- RNF129 (Grail2): Highly similar to RNF128
- RNF150: Brain-expressed family member
- RNF151: Testis-specific family member
This family is characterized by the conserved RING finger domain, transmembrane anchor, and proline-rich region, suggesting conserved functions in protein quality control across cell types.
Role in Neurodegenerative Diseases
Parkinson's Disease
A significant 2026 study demonstrated that RNF128 knockdown attenuates Parkinson's disease-induced mitochondrial dysfunction in neurons by stabilizing the SIRT1 protein[@knockdown2026]. This finding reveals a novel pathway linking RNF128 to neuronal survival in Parkinson's disease.
Mechanistic Pathway
Conversely, RNF128 knockdown:
- Reduces SIRT1 ubiquitination and degradation
- Stabilizes SIRT1 protein levels
- Preserves mitochondrial function
- Provides neuroprotection against Parkinson's disease pathology
Clinical Implications
The RNF128-SIRT1 axis represents a novel therapeutic target in Parkinson's disease. Several strategies are being explored:
| Strategy | Approach | Status |
|----------|----------|--------|
| RNF128 inhibitors | Small molecules targeting E3 ligase activity | Preclinical |
| RNAi knockdown | siRNA/shRNA to reduce RNF128 expression | Preclinical |
| SIRT1 stabilization | Compounds preventing RNF128-mediated degradation | Preclinical |
| Gene therapy | Viral delivery of RNF128-targeting constructs | Research |
Alzheimer's Disease
While direct evidence for RNF128 in Alzheimer's disease is limited, the protein's role in the ubiquitin-proteasome system connects it to several AD-relevant pathways[@mittal2021]:
Amyloid Processing: The ubiquitin-proteasome system is involved in clearance of amyloid precursor protein (APP) and its processing products. Dysregulation of E3 ligases like RNF128 could contribute to amyloid accumulation.
Tau Pathology: Protein quality control mechanisms are critical for clearance of hyperphosphorylated tau. RNF128-mediated ubiquitination may affect tau turnover.
Synaptic Function: Ubiquitin-dependent protein degradation regulates synaptic protein levels and plasticity. RNF128 activity could influence synaptic homeostasis in AD.
Amyotrophic Lateral Sclerosis (ALS)
Emerging evidence suggests RNF128 may play a role in ALS pathogenesis through:
- Regulation of protein aggregates
- ER stress response
- Mitochondrial quality control
The protein's function in ER-associated degradation (ERAD) is particularly relevant given the prominent role of ER stress in ALS[@nakamura2021].
Role in Neuroinflammation
RNF128 has been implicated in regulation of neuroinflammation through its effects on immune cell function[@hrdlicka2022]. The protein modulates:
- T cell activation and cytokine production
- Microglial inflammatory responses
- Astrocyte reactivity
SIRT1 Connection
[SIRT1](/entities/sirt1) (Sirtuin 1) is a NAD+-dependent deacetylase with well-established protective roles in neurodegenerative diseases[@wang2021]. SIRT1 promotes mitochondrial biogenesis and function through:
- PGC-1α deacetylation and activation
- TFAM expression enhancement
- Mitochondrial DNA replication support
- Oxidative stress resistance
- Anti-inflammatory effects via deacetylation of NF-κB
RNF128-mediated degradation of SIRT1 represents a novel regulatory mechanism that becomes dysregulated in Parkinson's disease[@knockdown2026]. The SIRT1-PGC-1α axis is a critical regulator of mitochondrial biogenesis, and its disruption contributes to dopaminergic neuron vulnerability.
Mechanistic Link to Mitochondrial Dysfunction
SIRT1 directly deacetylates and activates PGC-1α, the master regulator of mitochondrial biogenesis. When RNF128 ubiquitinates and promotes SIRT1 degradation:
This pathway connects RNF128 overexpression to the mitochondrial dysfunction that characterizes dopaminergic neuron loss in Parkinson's disease.
Ubiquitin-Proteasome System Context
The ubiquitin-proteasome system (UPS) is the primary mechanism for targeted protein degradation in eukaryotic cells[@saito2019]. RNF128 functions within this system as follows:
Ubiquitination Cascade
Types of Ubiquitination
RNF128 can catalyze different types of ubiquitin chains:
- K48-linked chains: Traditional degradation signal
- K63-linked chains: Non-degradative signaling
- Monoubiquitination: Signaling rather than degradation
Endoplasmic Reticulum Stress and ERAD
RNF128 is localized to the ER membrane and participates in ER-associated degradation (ERAD)[@choi2021]. This pathway handles:
- Misfolded proteins
- Unassembled protein complexes
- Stress-induced damaged proteins
Unfolded Protein Response
When ER homeostasis is disrupted, the unfolded protein response (UPR) is activated[@tai2020]. RNF128 expression can be modulated by UPR signaling, creating a feedback loop between protein quality control and ER stress.
Neurodegeneration Connection
ER stress is a prominent feature of many neurodegenerative diseases:
- Parkinson's: ER stress in dopaminergic neurons
- Alzheimer's: ER stress in vulnerable neurons
- ALS: Prominent ER stress in motor neurons
RNF128 dysregulation may contribute to ER stress-induced neuronal death.
Therapeutic Potential
The discovery of RNF128's role in Parkinson's disease opens several therapeutic avenues[@park2017]:
1. RNF128 Inhibitors
Small molecule inhibitors targeting RNF128 E3 ligase activity could prevent SIRT1 degradation in Parkinson's disease models. Challenges include:
- Achieving brain penetration
- Selectivity over other E3 ligases
- Avoiding disruption of essential cellular functions
2. Gene Therapy
RNAi-based approaches to knockdown RNF128 expression may provide neuroprotection. Viral vectors (AAV) could deliver:
- shRNA constructs
- siRNA sequences
- CRISPR-Cas9 targeting
3. SIRT1 Stabilization
Compounds that inhibit the RNF128-SIRT1 interaction could preserve SIRT1 levels. Known SIRT1 activators include:
- Resveratrol
- SRT2104
- SRT1720
4. Combination Therapies
RNF128-targeted approaches combined with [SIRT1 activators](/mechanisms/sirtuins-neurodegeneration) may provide synergistic neuroprotection.
Related Pathways
- [Ubiquitin-Proteasome System](/mechanisms/ubiquitin-proteasome-system)
- [Mitochondrial Quality Control](/mechanisms/mitochondrial-quality-control)
- [Mitochondrial Dysfunction in Dopaminergic Neurons](/cell-types/mitochondrial-dysfunction-dopaminergic)
- [Sirtuins in Neurodegeneration](/mechanisms/sirtuins-neurodegeneration)
- [Neuroinflammation in Parkinson's Disease](/mechanisms/neuroinflammation-parkinsons)
- [Endoplasmic Reticulum Stress](/mechanisms/er-stress-unfolded-protein-response)
- [Protein Aggregation](/mechanisms/protein-aggregation-neurodegeneration)
Animal Models
Research on RNF128 has utilized several model systems:
- Knockout mice: RNF128-deficient mice show enhanced T cell responses
- Transgenic models: Neuronal RNF128 overexpression models
- Drosophila: Homologs used to study ER stress
- Cell culture: Primary neurons and neuronal cell lines
Biomarkers and Diagnostics
Potential biomarkers related to RNF128 dysfunction:
- SIRT1 protein levels in patient neurons
- RNF128 expression in peripheral blood mononuclear cells
- Ubiquitinated SIRT1 as a readout of RNF128 activity
Future Directions
Key questions remain unanswered:
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [SIRT1](/entities/sirt1)
- [Ubiquitin-Proteasome System](/mechanisms/ubiquitin-proteasome-system)
- [Mitochondrial Quality Control](/mechanisms/mitochondrial-quality-control)
External Links
- [GeneCards - RNF128](https://www.genecards.org/cgi-bin/carddisp.pl?gene=RNF128)
- [UniProt - RNF128](https://www.uniprot.org/uniprot/Q9H6X0)
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
- [Allen Human Brain Atlas](https://brain-map.org/)
References
Pathway Diagram
The following diagram shows the key molecular relationships involving RNF128 (Graf1/XTP3) Gene discovered through SciDEX knowledge graph analysis:
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | entities-rnf128 |
| kg_node_id | None |
| entity_type | entity |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-faecb0f1ee43 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'entities-rnf128'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-entities-rnf128?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[RNF128 (Graf1/XTP3) Gene](http://scidex.ai/artifact/wiki-entities-rnf128)
http://scidex.ai/artifact/wiki-entities-rnf128